Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke)

Journal of the American College of Cardiology

Volumn 63, Issue 16, 2014, Pages 1626-1633

  Brown, Todd M ^a   Voeks, Jenifer H ^b   Bittner, Vera ^a   Brenner, David A ^c   Cushman, Mary ^d   Goff Jr , David C ^e   Glasser, Stephen ^a   Muntner, Paul ^c   Tabereaux, Paul B ^f   Safford, Monika M ^a  

^a University of Alabama at Birmingham   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e Food Science and Human Nutrition   (United States)

^f HUNTSVILLE HOSPITAL   (United States)

Author keywords

coronary artery disease; prevention; risk factors

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE; RACE DIFFERENCE; RISK REDUCTION; SEX DIFFERENCE; SEX RATIO; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

CORONARY ARTERY DISEASE; PREVENTION; RISK FACTORS;

AGED; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GOALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; STROKE; SURVIVAL RATE; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 84898971075     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.12.042     Document Type: Article

References (30)

1. A.S. Go, D. Mozaffarian, V.L. Roger on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
2. S.D. Fihn, J.M. Gardin, and J. Abrams et al. 2012 ACCF/AHA/ACP/AATS/PCNA/ SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease J Am Coll Cardiol 60 2012 e44 e164
3. G.A. Lin, R.A. Dudley, and R.F. Redberg Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease Arch Intern Med 167 2007 1604 1609
4. M.B. Rothberg, S.K. Sivalingam, and J. Ashraf et al. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease Ann Intern Med 153 2010 307 313
5. D.N. Feldman, C.L. Gade, and A.J. Slotwiner et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (< 60, 60 to 80, and > 80 years) (from the New York state Angioplasty Registry) Am J Cardiol 98 2006 1334 1339
6. W.E. Boden, R.A. O'Rourke, and K.K. Teo et al. Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
7. T.M. Brown, and V. Bittner The management of stable patients with coronary heart disease: clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial J Clin Lipidol 1 2007 564 574
8. V.J. Howard, M. Cushman, and L.V. Pulley et al. The REasons for Geographic And Racial Differences in Stroke (REGARDS) study: objectives and design Neuroepidemiology 25 2005 135 143
9. W.E. Boden, R.A. O'Rourke, and K.K. Teo et al. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial: Veterans Affairs Cooperative Studies Program no. 424 Am Heart J 151 2006 1173 1179
10. D.J. Maron, W.E. Boden, and R.A. O'Rourke et al. Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial J Am Coll Cardiol 55 2010 1348 1358
11. J.P. Drozda, J.V. Messer, and J. Spertus ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension J Am Coll Cardiol 58 2011 316 336
12. D.M. Lloyd-Jones, Y. Hong, and D. Labarthe et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond Circulation 121 2010 586 613
13. American Diabetes Association Standards of medical care in diabetes- 2011 Diabetes Care 34 Suppl 1 2011 S11 S61
14. J. Ware Jr., M. Kosinski, and S.D. Keller A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 34 1996 220 233
15. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth for the Modification in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
16. L.A. Melchior, G.J. Huba, V.B. Brown, and C.J. Reback A short depression index for women Educ Psychol Measure 53 1993 1117 1125
17. W.B. Borden, R.F. Redberg, A.I. Mushlin, D. Dai, L.A. Kaltenbach, and J.A. Spertus Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention JAMA 305 2011 1882 1889
18. M.E. Farkouh, W.E. Boden, and V. Bittner et al. Risk factor control for coronary artery disease secondary prevention in large randomized trials J Am Coll Cardiol 61 2013 1607 1615
19. A.F. Parisi, E.D. Folland, and P. Hartigan et al. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease N Engl J Med 326 1992 10 16
20. RITA-2 trial participants Coronary angioplasty versus medical therapy for angina: the second Randomized Intervention Treatment of Angina (RITA-2) trial Lancet 350 1997 461 468
21. B. Pitt, D. Waters, and W.V. Brown et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease N Engl J Med 341 1999 70 76
22. W. Hueb, P.R. Soares, and B.J. Gersh et al. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results J Am Coll Cardiol 43 2004 1743 1751
23. R.A. Henderson, S.J. Pocock, and T.C. Clayton et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy J Am Coll Cardiol 42 2003 1161 1170
24. W.S. Weintraub, W.E. Boden, and Z. Zhang et al. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients Circ Cardiovasc Qual Outcomes 1 2008 12 20
25. B. Ahmed, H.L. Dauerman, and W.D. Piper et al. Recent changes in practice of elective percutaneous coronary intervention for stable angina Circ Cardiovasc Qual Outcomes 4 2011 300 405
26. A.K. Berger, S.J. Duval, C. Armstrong, D.R. Jacobs, and R.V. Luepker Contemporary diagnosis and management of hypercholesterolema in elderly acute myocardial infarction patients: a population-based study Am J Geriatr Cardiol 16 2007 15 23
27. J.D. Bisognano, K.A. Townsend, A.J. Skyles, and K.M. Samuels Prevalence of comorbidities and their influence on blood pressure goal attainment in geriatric patients Am J Geriatr Cardiol 16 2007 24 29
28. P. Muntner, E.B. Levitan, and T.M. Brown et al. Trends in prevalence, awareness, treatment, and control of high density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010 Am J Cardiol 112 2013 664 670
29. P.M. Ho, F.A. Masoudi, and E.D. Peterson et al. Cardiology management improves secondary prevention measures among patients with coronary artery disease J Am Coll Cardiol 43 2004 1517 1523
30. L.K. Newby, N.M. LaPointe, and A.Y. Chen et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212